Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

Ovarian cancer is the leading cause of death from gynecologic malignancy in the Western world. This is due, in part, to the fact that despite standard treatment of surgery and platinum/paclitaxel most patients recur with ultimately chemoresistant disease. Ovarian cancer is a unique form of solid tum...

Full description

Bibliographic Details
Main Authors: Edith Emmings, Sally Mullany, Zenas Chang, Charles N. Landen, Stig Linder, Martina Bazzaro
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:International Journal of Molecular Sciences
Subjects:
ascites
OXPHOS
mitochondrial inhibitor
chemoresistant ovarian cancer
SWI/SNF complex
Online Access:http://www.mdpi.com/1422-0067/20/1/229

Internet

http://www.mdpi.com/1422-0067/20/1/229

Similar Items